AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28556962 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-h IV retosiban followed by a single dose of oral placebo (R-P)
Number of subjects: 29
Study 28556962 — intervention group
Group type: COMPARATOR
Intervention: 12-h IV placebo followed by single-dose oral retosiban (P-R)
Number of subjects: 29
Study 25074756 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical brimonidine tartrate (BT) 0.5% gel, applied once daily for 4 weeks
Number of subjects: 553
Study 25074756 — intervention group
Group type: COMPARATOR
Intervention: Vehicle gel, applied once daily for 4 weeks
Number of subjects: 553
Study 23345118 — intervention group
Group type: EXPERIMENTAL
Intervention: Forewarned participants about the nature of the DRM task prior to encoding (Exp. 1)
Number of subjects: 0
Study 23345118 — intervention group
Group type: COMPARATOR
Intervention: Participants not forewarned about the nature of the DRM task (Exp. 2)
Number of subjects: 0
Study 21205412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation program
Number of subjects: 0
Study 21205412 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 17919545 — intervention group
Group type: EXPERIMENTAL
Intervention: Garenoxacin 400 mg QD for 5 days
Number of subjects: 546
Study 17919545 — intervention group
Group type: EXPERIMENTAL
Intervention: Garenoxacin 400 mg QD for 10 days
Number of subjects: 546
Study 17919545 — intervention group
Group type: EXPERIMENTAL
Intervention: Garenoxacin 400 mg QD for 5 or 10 days
Number of subjects: 546
Study 15688694 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangfu Xiaozheng Tablet
Number of subjects: 120
Study 15688694 — intervention group
Group type: COMPARATOR
Intervention: Guizhi Fuling Pill
Number of subjects: 120
Study 11160062 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (300 mg)
Number of subjects: 21
Study 11160062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 11160062 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen and Placebo
Number of subjects: 21
Study 9708579 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical process control (SPC) methods
Number of subjects: 0
Study 9708579 — intervention group
Group type: EXPERIMENTAL
Intervention: Run charts, control charts, and regression models
Number of subjects: 0
Study 8270982 — intervention group
Group type: EXPERIMENTAL
Intervention: DAVTH reinduction after relapse
Number of subjects: 106
Study 8270982 — intervention group
Group type: COMPARATOR
Intervention: Observation after induction CR
Number of subjects: 106
Study 2643965 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesics and a standard circumferential rib belt (Zimmer Universal Rib Belt)
Number of subjects: 25
Study 2643965 — intervention group
Group type: COMPARATOR
Intervention: Oral analgesics alone
Number of subjects: 25
Study 31564599 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco prevention presentation
Number of subjects: 2257
Study 31564599 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no presentation)
Number of subjects: 2257
Study 29753538 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulant (OAC) indication
Number of subjects: 969
Study 26297321 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalist Approach - Brief Intervention (BI) delivered by primary care provider
Number of subjects: 7
Study 26297321 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist Approach - Brief Intervention (BI) delivered by behavioral health counselors
Number of subjects: 7
Study 26297321 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of HIV risk screening within SBIRT model
Number of subjects: 7
Study 26297321 — intervention group
Group type: COMPARATOR
Intervention: Implementation Strategies
Number of subjects: 7
Study 24732127 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenolization with curettage
Number of subjects: 90
Study 24732127 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenolization alone
Number of subjects: 90
Study 24732127 — intervention group
Group type: COMPARATOR
Intervention: Curettage
Number of subjects: 90
Study 24732127 — intervention group
Group type: COMPARATOR
Intervention: Phenolization
Number of subjects: 90
Study 23089925 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins treatment for 2 weeks
Number of subjects: 720
Study 23089925 — intervention group
Group type: COMPARATOR
Intervention: Control groups (normal and high-risk)
Number of subjects: 720
Study 20166405 — intervention group
Group type: EXPERIMENTAL
Intervention: HB (at-home bleaching with 10% carbamide peroxide for two weeks)
Number of subjects: 90
Study 20166405 — intervention group
Group type: COMPARATOR
Intervention: OBL (in-office bleaching with 35% hydrogen peroxide, two sessions, two-week intervals, with light irradiation)
Number of subjects: 90
Study 20166405 — intervention group
Group type: COMPARATOR
Intervention: OB (in-office bleaching without light irradiation)
Number of subjects: 90
Study 20166405 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (one session plus HB)
Number of subjects: 90
Study 20166405 — intervention group
Group type: EXPERIMENTAL
Intervention: HE (home bleaching)
Number of subjects: 90
Study 20166405 — intervention group
Group type: COMPARATOR
Intervention: OBL and OB
Number of subjects: 90
Study 18398079 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE-RFA
Number of subjects: 291
Study 18398079 — intervention group
Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 291
Study 18398079 — intervention group
Group type: COMPARATOR
Intervention: RFA alone
Number of subjects: 291
Study 16047223 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole 2.5 mg/kg on alternate days
Number of subjects: 40
Study 16047223 — intervention group
Group type: COMPARATOR
Intervention: I.V. cyclophosphamide 500 mg/m2/month for six months
Number of subjects: 40
Study 21067347 — intervention group
Group type: EXPERIMENTAL
Intervention: Val 160/HCTZ 12.5
Number of subjects: 2002
Study 21067347 — intervention group
Group type: EXPERIMENTAL
Intervention: Val 160/HCTZ 25
Number of subjects: 2002
Study 21067347 — intervention group
Group type: COMPARATOR
Intervention: Val 160
Number of subjects: 2002
Study 10820175 — intervention group
Group type: COMPARATOR
Intervention: 15 mg/d folic acid
Number of subjects: 150
Study 10820175 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/d folic acid
Number of subjects: 150
Study 10820175 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/d folic acid
Number of subjects: 150
Study 10820175 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/d folic acid in MTHFR 677TT genotype patients
Number of subjects: 150
Study 10820175 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 or 60 mg/d folic acid
Number of subjects: 150
Study 10820175 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR 677TT genotype
Number of subjects: 150
Study 8785167 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tretinoin
Number of subjects: 27
Study 1514338 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent wound infiltration with bupivacaine and continuous coeliac plexus blockade (total 862.5 mg over 12 h)
Number of subjects: 20
Study 1514338 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 20
Study 1514338 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent wound infiltration with bupivacaine and continuous coeliac plexus blockade
Number of subjects: 20
Study 6341873 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic oral taurine administration
Number of subjects: 9
Study 6341873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 29943100 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-tenon steroid injection (Triamcinolone acetonide) plus anti-VEGF injection
Number of subjects: 0
Study 29943100 — intervention group
Group type: COMPARATOR
Intervention: Anti-VEGF injection only
Number of subjects: 0
Study 28334499 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal Root Ganglion (DRG) stimulation
Number of subjects: 12
Study 28334499 — intervention group
Group type: COMPARATOR
Intervention: Dorsal Column (DC) stimulation
Number of subjects: 12
Study 27112245 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone addition group (400 mg)
Number of subjects: 90
Study 27112245 — intervention group
Group type: EXPERIMENTAL
Intervention: Water addition group (1 L)
Number of subjects: 90
Study 27112245 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone addition group
Number of subjects: 90
Study 27112245 — intervention group
Group type: COMPARATOR
Intervention: PEGA group
Number of subjects: 90
Study 25246693 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate‐amodiaquine
Number of subjects: 747
Study 25246693 — intervention group
Group type: COMPARATOR
Intervention: Artemether‐lumefantrine
Number of subjects: 747
Study 25246693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 747
Study 22541389 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 695
Study 22541389 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (watchful waiting)
Number of subjects: 695
Study 19053054 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Botox)
Number of subjects: 300
Study 19053054 — intervention group
Group type: EXPERIMENTAL
Intervention: NT201 (Xeomin)
Number of subjects: 300
Study 19053054 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin type A (Botox) and NT201 (Xeomin)
Number of subjects: 300
Study 17669862 — intervention group
Group type: EXPERIMENTAL
Intervention: Edwards Perimount Magna (EPM) valve
Number of subjects: 86
Study 17669862 — intervention group
Group type: COMPARATOR
Intervention: Medtronic Mosaic (MM) bioprosthesis
Number of subjects: 86
Study 16294803 — intervention group
Group type: EXPERIMENTAL
Intervention: SimplyThick
Number of subjects: 43
Study 16294803 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick-It
Number of subjects: 43
Study 16294803 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural thickeners
Number of subjects: 43
Study 16294803 — intervention group
Group type: COMPARATOR
Intervention: Commercial thickeners
Number of subjects: 43
Study 11980869 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony stimulating factor (G-CSF, 300 microg)
Number of subjects: 15
Study 11980869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 10636597 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier sucking
Number of subjects: 10
Study 10636597 — intervention group
Group type: EXPERIMENTAL
Intervention: Digit sucking
Number of subjects: 10
Study 10636597 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed sharing
Number of subjects: 10
Study 10636597 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-routine location
Number of subjects: 10
Study 10636597 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking
Number of subjects: 10
Study 7552468 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep acupuncture
Number of subjects: 20
Study 7552468 — intervention group
Group type: COMPARATOR
Intervention: Superficial acupuncture
Number of subjects: 20
Study 1773316 — intervention group
Group type: EXPERIMENTAL
Intervention: Division of lateral ligaments during rectopexy
Number of subjects: 26
Study 1773316 — intervention group
Group type: COMPARATOR
Intervention: Preservation of lateral ligaments during rectopexy
Number of subjects: 26
Study 6982270 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold cardioplegia with topical deep hypothermia using Bretschneider solution
Number of subjects: 20
Study 6982270 — intervention group
Group type: COMPARATOR
Intervention: Intermittent aortic cross clamping at 30 degrees C
Number of subjects: 20
Study 31810378 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Number of subjects: 20
Study 31810378 — intervention group
Group type: COMPARATOR
Intervention: Normal Sleep
Number of subjects: 20
Study 31192515 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection into the right masseter muscle
Number of subjects: 42
Study 31192515 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (IS) injection into the right masseter muscle
Number of subjects: 42
Study 27341122 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Misoprostol
Number of subjects: 502
Study 27341122 — intervention group
Group type: COMPARATOR
Intervention: Foley Catheter
Number of subjects: 502
Study 26950019 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine, Lithium Carbonate, or Valproic Acid (monotherapy)
Number of subjects: 68
Study 23102577 — intervention group
Group type: EXPERIMENTAL
Intervention: External cephalic version (ECV)
Number of subjects: 212
Study 25426786 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical + intrasulcular hyaluronan gel
Number of subjects: 28
Study 25426786 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical hyaluronan gel
Number of subjects: 28
Study 25426786 — intervention group
Group type: COMPARATOR
Intervention: Scaling
Number of subjects: 28
Study 25426786 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling + topical hyaluronan gel
Number of subjects: 28
Study 19016469 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 1094
Study 19016469 — intervention group
Group type: COMPARATOR
Intervention: Ticlopidine
Number of subjects: 1094
Study 16928941 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced sonography
Number of subjects: 186
Study 16928941 — intervention group
Group type: COMPARATOR
Intervention: Unenhanced sonography
Number of subjects: 186
Study 14624399 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training group (CT) - weight training plus aerobic training
Number of subjects: 36
Study 14624399 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training group (AT) - aerobic training only
Number of subjects: 36
Study 14624399 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no exercise
Number of subjects: 36
Study 10625096 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate supplementation of human milk
Number of subjects: 127
Study 10625096 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified supplementation with protein, calcium, and phosphorus
Number of subjects: 127
Study 10625096 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm formula
Number of subjects: 127
Study 10625096 — intervention group
Group type: COMPARATOR
Intervention: Own mother's milk only
Number of subjects: 127
Study 9206860 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent prophylaxis (diazepam at fever)
Number of subjects: 289
Study 9206860 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis (diazepam at seizures)
Number of subjects: 289
Study 1304644 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniwright peak flow meter
Number of subjects: 100
Study 1304644 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitalograph peak flow meter
Number of subjects: 100
Study 1304644 — intervention group
Group type: EXPERIMENTAL
Intervention: Assess peak flow meter
Number of subjects: 100
Study 3519550 — intervention group
Group type: EXPERIMENTAL
Intervention: 60Co radiation
Number of subjects: 1115
Study 3519550 — intervention group
Group type: COMPARATOR
Intervention: Conventional roentgen unit
Number of subjects: 1115
Study 30232551 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intraoperative electromyographic neuromonitoring
Number of subjects: 106
Study 30232551 — intervention group
Group type: COMPARATOR
Intervention: Control (no continuous intraoperative electromyographic neuromonitoring)
Number of subjects: 106
Study 26545174 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiband mucosectomy (MBM)
Number of subjects: 84
Study 26545174 — intervention group
Group type: COMPARATOR
Intervention: Cap-assisted endoscopic resection
Number of subjects: 84
Study 25366542 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion intervention delivered quarterly over 15 months, involving educational activities, peer discussion, a DVD, and written materials
Number of subjects: 542
Study 25366542 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 542
Study 21766226 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental arm exercise (10 W min(‐1))
Number of subjects: 10
Study 21766226 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental leg exercise (25 W min(‐1))
Number of subjects: 10
Study 21766226 — intervention group
Group type: COMPARATOR
Intervention: Reference test (RT)
Number of subjects: 10
Study 21766226 — intervention group
Group type: EXPERIMENTAL
Intervention: AL (Incremental ramp exercise)
Number of subjects: 10
Study 21766226 — intervention group
Group type: EXPERIMENTAL
Intervention: LL (Incremental ramp exercise)
Number of subjects: 10
Study 21766226 — intervention group
Group type: EXPERIMENTAL
Intervention: LL
Number of subjects: 10
Study 21214094 — intervention group
Group type: EXPERIMENTAL
Intervention: Beating-heart technique with retrograde coronary sinus perfusion
Number of subjects: 35
Study 21214094 — intervention group
Group type: COMPARATOR
Intervention: Conventional aortic valve replacement
Number of subjects: 35
Study 18386255 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Pycnogenol daily (oral capsules)
Number of subjects: 156
Study 18386255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 18077797 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 177
Study 18077797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 15218810 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular interferon-beta Ia
Number of subjects: 50
Study 15218810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11719893 — intervention group
Group type: EXPERIMENTAL
Intervention: H-high (hypoxia, high intensity)
Number of subjects: 33
Study 11719893 — intervention group
Group type: EXPERIMENTAL
Intervention: N-high (normoxia, high intensity)
Number of subjects: 33
Study 11719893 — intervention group
Group type: EXPERIMENTAL
Intervention: H-low (hypoxia, low intensity)
Number of subjects: 33
Study 11719893 — intervention group
Group type: EXPERIMENTAL
Intervention: N-low (normoxia, low intensity)
Number of subjects: 33
Study 9424007 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbogen
Number of subjects: 35
Study 9424007 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide (80 mg/kg/day)
Number of subjects: 35
Study 9424007 — intervention group
Group type: EXPERIMENTAL
Intervention: ARCON (Accelerated Radiotherapy, CarbOgen, Nicotinamide)
Number of subjects: 35
Study 9424007 — intervention group
Group type: COMPARATOR
Intervention: CHART (Control)
Number of subjects: 35
Study 8479489 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone (750 mg, orally, three times daily for 21 days)
Number of subjects: 322
Study 8479489 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim (320 mg) plus sulfamethoxazole (1600 mg, orally, three times daily for 21 days)
Number of subjects: 322
Study 8479489 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone
Number of subjects: 322
Study 8479489 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 322
Study 3565410 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacy services provided by two pharmacists to a randomly selected cluster of family practice physicians for six months.
Number of subjects: 0
Study 3565410 — intervention group
Group type: COMPARATOR
Intervention: Control group of family practice physicians who did not receive clinical pharmacy services.
Number of subjects: 0
Study 3565410 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups.
Number of subjects: 0
Study 30663775 — intervention group
Group type: EXPERIMENTAL
Intervention: On-line intervention
Number of subjects: 60
Study 30663775 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 60
Study 30402136 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 69
Study 30402136 — intervention group
Group type: COMPARATOR
Intervention: Control Group 1 (CTR 1)
Number of subjects: 69
Study 30402136 — intervention group
Group type: COMPARATOR
Intervention: Control Group 2 (CTR 2)
Number of subjects: 69
Study 30402136 — intervention group
Group type: COMPARATOR
Intervention: Control Group 3 (CTR 3)
Number of subjects: 69
Study 26878318 — intervention group
Group type: EXPERIMENTAL
Intervention: Boiled and mashed potatoes (BMP)
Number of subjects: 34
Study 26878318 — intervention group
Group type: EXPERIMENTAL
Intervention: Fried French fries (FFF)
Number of subjects: 34
Study 26878318 — intervention group
Group type: COMPARATOR
Intervention: Rice, pasta, baked French fries (BFF)
Number of subjects: 34
Study 25392505 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory aversive conditioning during stage 2 sleep
Number of subjects: 66
Study 25392505 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory aversive conditioning during REM sleep
Number of subjects: 66
Study 25392505 — intervention group
Group type: COMPARATOR
Intervention: Control sleep experiments (aversive odors alone and effects of cigarette odors and aversive odors without pairing)
Number of subjects: 66
Study 22949277 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention designed to improve the quality of life of spousal caregivers
Number of subjects: 0
Study 21129179 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-led teaching module incorporated into the mandatory training of junior doctors on patient safety.
Number of subjects: 0
Study 21129179 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes to Patient Safety Questionnaire (APSQ) as the primary quantitative outcome measure.
Number of subjects: 0
Study 17980044 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 36
Study 17980044 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture (TCA)
Number of subjects: 36
Study 17980044 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (Sham)
Number of subjects: 36
Study 15800019 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose reteplase
Number of subjects: 11420
Study 15800019 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose reteplase plus abciximab
Number of subjects: 11420
Study 15800019 — intervention group
Group type: COMPARATOR
Intervention: Both groups (standard-dose reteplase and half-dose reteplase plus abciximab)
Number of subjects: 11420